Global Exoskeleton Enhancement Device Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global Exoskeleton Enhancement Device market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Exoskeleton Enhancement Device is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Exoskeleton Enhancement Device is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Exoskeleton Enhancement Device is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Exoskeleton Enhancement Device include Parker Hannifin, US Bionics, ReWalk Robotics, Panasonic, Myomo, LockHeed Martin, Interactive Motion Technologies, Hocoma and Ekso Bionics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Exoskeleton Enhancement Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exoskeleton Enhancement Device.
The Exoskeleton Enhancement Device market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Exoskeleton Enhancement Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Exoskeleton Enhancement Device Segment by Company

Parker Hannifin
US Bionics
ReWalk Robotics
Panasonic
Myomo
LockHeed Martin
Interactive Motion Technologies
Hocoma
Ekso Bionics
Cyberdyne
B-TEMIA Inc.
Alter G
Exoskeleton Enhancement Device Segment by Type

Lower
Upper
Full Body
Exoskeleton Enhancement Device Segment by Application

Healthcare
Defense
Others
Exoskeleton Enhancement Device Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exoskeleton Enhancement Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exoskeleton Enhancement Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exoskeleton Enhancement Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exoskeleton Enhancement Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Exoskeleton Enhancement Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Exoskeleton Enhancement Device Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Exoskeleton Enhancement Device Sales Estimates and Forecasts (2020-2031)
1.3 Exoskeleton Enhancement Device Market by Type
1.3.1 Lower
1.3.2 Upper
1.3.3 Full Body
1.4 Global Exoskeleton Enhancement Device Market Size by Type
1.4.1 Global Exoskeleton Enhancement Device Market Size Overview by Type (2020-2031)
1.4.2 Global Exoskeleton Enhancement Device Historic Market Size Review by Type (2020-2025)
1.4.3 Global Exoskeleton Enhancement Device Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Exoskeleton Enhancement Device Sales Breakdown by Type (2020-2025)
1.5.2 Europe Exoskeleton Enhancement Device Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Exoskeleton Enhancement Device Sales Breakdown by Type (2020-2025)
1.5.4 South America Exoskeleton Enhancement Device Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Exoskeleton Enhancement Device Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Exoskeleton Enhancement Device Industry Trends
2.2 Exoskeleton Enhancement Device Industry Drivers
2.3 Exoskeleton Enhancement Device Industry Opportunities and Challenges
2.4 Exoskeleton Enhancement Device Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Exoskeleton Enhancement Device Revenue (2020-2025)
3.2 Global Top Players by Exoskeleton Enhancement Device Sales (2020-2025)
3.3 Global Top Players by Exoskeleton Enhancement Device Price (2020-2025)
3.4 Global Exoskeleton Enhancement Device Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Exoskeleton Enhancement Device Major Company Production Sites & Headquarters
3.6 Global Exoskeleton Enhancement Device Company, Product Type & Application
3.7 Global Exoskeleton Enhancement Device Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Exoskeleton Enhancement Device Market CR5 and HHI
3.8.2 Global Top 5 and 10 Exoskeleton Enhancement Device Players Market Share by Revenue in 2024
3.8.3 2023 Exoskeleton Enhancement Device Tier 1, Tier 2, and Tier 3
4 Exoskeleton Enhancement Device Regional Status and Outlook
4.1 Global Exoskeleton Enhancement Device Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Exoskeleton Enhancement Device Historic Market Size by Region
4.2.1 Global Exoskeleton Enhancement Device Sales in Volume by Region (2020-2025)
4.2.2 Global Exoskeleton Enhancement Device Sales in Value by Region (2020-2025)
4.2.3 Global Exoskeleton Enhancement Device Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Exoskeleton Enhancement Device Forecasted Market Size by Region
4.3.1 Global Exoskeleton Enhancement Device Sales in Volume by Region (2026-2031)
4.3.2 Global Exoskeleton Enhancement Device Sales in Value by Region (2026-2031)
4.3.3 Global Exoskeleton Enhancement Device Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Exoskeleton Enhancement Device by Application
5.1 Exoskeleton Enhancement Device Market by Application
5.1.1 Healthcare
5.1.2 Defense
5.1.3 Others
5.2 Global Exoskeleton Enhancement Device Market Size by Application
5.2.1 Global Exoskeleton Enhancement Device Market Size Overview by Application (2020-2031)
5.2.2 Global Exoskeleton Enhancement Device Historic Market Size Review by Application (2020-2025)
5.2.3 Global Exoskeleton Enhancement Device Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Exoskeleton Enhancement Device Sales Breakdown by Application (2020-2025)
5.3.2 Europe Exoskeleton Enhancement Device Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Exoskeleton Enhancement Device Sales Breakdown by Application (2020-2025)
5.3.4 South America Exoskeleton Enhancement Device Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Exoskeleton Enhancement Device Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Parker Hannifin
6.1.1 Parker Hannifin Comapny Information
6.1.2 Parker Hannifin Business Overview
6.1.3 Parker Hannifin Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Parker Hannifin Exoskeleton Enhancement Device Product Portfolio
6.1.5 Parker Hannifin Recent Developments
6.2 US Bionics
6.2.1 US Bionics Comapny Information
6.2.2 US Bionics Business Overview
6.2.3 US Bionics Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 US Bionics Exoskeleton Enhancement Device Product Portfolio
6.2.5 US Bionics Recent Developments
6.3 ReWalk Robotics
6.3.1 ReWalk Robotics Comapny Information
6.3.2 ReWalk Robotics Business Overview
6.3.3 ReWalk Robotics Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ReWalk Robotics Exoskeleton Enhancement Device Product Portfolio
6.3.5 ReWalk Robotics Recent Developments
6.4 Panasonic
6.4.1 Panasonic Comapny Information
6.4.2 Panasonic Business Overview
6.4.3 Panasonic Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Panasonic Exoskeleton Enhancement Device Product Portfolio
6.4.5 Panasonic Recent Developments
6.5 Myomo
6.5.1 Myomo Comapny Information
6.5.2 Myomo Business Overview
6.5.3 Myomo Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Myomo Exoskeleton Enhancement Device Product Portfolio
6.5.5 Myomo Recent Developments
6.6 LockHeed Martin
6.6.1 LockHeed Martin Comapny Information
6.6.2 LockHeed Martin Business Overview
6.6.3 LockHeed Martin Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 LockHeed Martin Exoskeleton Enhancement Device Product Portfolio
6.6.5 LockHeed Martin Recent Developments
6.7 Interactive Motion Technologies
6.7.1 Interactive Motion Technologies Comapny Information
6.7.2 Interactive Motion Technologies Business Overview
6.7.3 Interactive Motion Technologies Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Interactive Motion Technologies Exoskeleton Enhancement Device Product Portfolio
6.7.5 Interactive Motion Technologies Recent Developments
6.8 Hocoma
6.8.1 Hocoma Comapny Information
6.8.2 Hocoma Business Overview
6.8.3 Hocoma Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hocoma Exoskeleton Enhancement Device Product Portfolio
6.8.5 Hocoma Recent Developments
6.9 Ekso Bionics
6.9.1 Ekso Bionics Comapny Information
6.9.2 Ekso Bionics Business Overview
6.9.3 Ekso Bionics Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ekso Bionics Exoskeleton Enhancement Device Product Portfolio
6.9.5 Ekso Bionics Recent Developments
6.10 Cyberdyne
6.10.1 Cyberdyne Comapny Information
6.10.2 Cyberdyne Business Overview
6.10.3 Cyberdyne Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Cyberdyne Exoskeleton Enhancement Device Product Portfolio
6.10.5 Cyberdyne Recent Developments
6.11 B-TEMIA Inc.
6.11.1 B-TEMIA Inc. Comapny Information
6.11.2 B-TEMIA Inc. Business Overview
6.11.3 B-TEMIA Inc. Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 B-TEMIA Inc. Exoskeleton Enhancement Device Product Portfolio
6.11.5 B-TEMIA Inc. Recent Developments
6.12 Alter G
6.12.1 Alter G Comapny Information
6.12.2 Alter G Business Overview
6.12.3 Alter G Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Alter G Exoskeleton Enhancement Device Product Portfolio
6.12.5 Alter G Recent Developments
7 North America by Country
7.1 North America Exoskeleton Enhancement Device Sales by Country
7.1.1 North America Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Exoskeleton Enhancement Device Sales by Country (2020-2025)
7.1.3 North America Exoskeleton Enhancement Device Sales Forecast by Country (2026-2031)
7.2 North America Exoskeleton Enhancement Device Market Size by Country
7.2.1 North America Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Exoskeleton Enhancement Device Market Size by Country (2020-2025)
7.2.3 North America Exoskeleton Enhancement Device Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Exoskeleton Enhancement Device Sales by Country
8.1.1 Europe Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Exoskeleton Enhancement Device Sales by Country (2020-2025)
8.1.3 Europe Exoskeleton Enhancement Device Sales Forecast by Country (2026-2031)
8.2 Europe Exoskeleton Enhancement Device Market Size by Country
8.2.1 Europe Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Exoskeleton Enhancement Device Market Size by Country (2020-2025)
8.2.3 Europe Exoskeleton Enhancement Device Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Exoskeleton Enhancement Device Sales by Country
9.1.1 Asia-Pacific Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Exoskeleton Enhancement Device Sales by Country (2020-2025)
9.1.3 Asia-Pacific Exoskeleton Enhancement Device Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Exoskeleton Enhancement Device Market Size by Country
9.2.1 Asia-Pacific Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Exoskeleton Enhancement Device Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Exoskeleton Enhancement Device Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Exoskeleton Enhancement Device Sales by Country
10.1.1 South America Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Exoskeleton Enhancement Device Sales by Country (2020-2025)
10.1.3 South America Exoskeleton Enhancement Device Sales Forecast by Country (2026-2031)
10.2 South America Exoskeleton Enhancement Device Market Size by Country
10.2.1 South America Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Exoskeleton Enhancement Device Market Size by Country (2020-2025)
10.2.3 South America Exoskeleton Enhancement Device Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Exoskeleton Enhancement Device Sales by Country
11.1.1 Middle East and Africa Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Exoskeleton Enhancement Device Sales by Country (2020-2025)
11.1.3 Middle East and Africa Exoskeleton Enhancement Device Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Exoskeleton Enhancement Device Market Size by Country
11.2.1 Middle East and Africa Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Exoskeleton Enhancement Device Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Exoskeleton Enhancement Device Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Exoskeleton Enhancement Device Value Chain Analysis
12.1.1 Exoskeleton Enhancement Device Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Exoskeleton Enhancement Device Production Mode & Process
12.2 Exoskeleton Enhancement Device Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Exoskeleton Enhancement Device Distributors
12.2.3 Exoskeleton Enhancement Device Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings